drugset
drugset / Trial / NCT07023107

NLR and PLR Levels Following PENG Block in Hip Arthroplasty

NCT07023107 ↗

Phase 4 Completed 60 enrolled Poznan University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Effect of PENG block on NLR and PLR following hip arthroplasty

Timeline

Start
2025-06-16
Primary completion
2025-12-09
Completion
2025-12-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 20 ml —

Indications

chronic pain syndrome osteoarthritis, hip